Dow Down1.29% Nasdaq Down3.25%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqCM
0.37 Down 0.01(3.90%) Feb 5, 3:53PM EST
|After Hours : 0.35 Down 0.02 (4.11%) Feb 5, 5:10PM EST
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 15
Next Qtr.
Mar 16
Current Year
Dec 15
Next Year
Dec 16
Avg. Estimate-0.08N/A-0.43-0.49
No. of Analysts1.00N/A1.001.00
Low Estimate-0.08N/A-0.43-0.49
High Estimate-0.08N/A-0.43-0.49
Year Ago EPS-0.22-0.21-0.89-0.43
Revenue EstCurrent Qtr.
Dec 15
Next Qtr.
Mar 16
Current Year
Dec 15
Next Year
Dec 16
Avg. Estimate510.00KNaN2.03M1.62M
No. of Analysts111
Low Estimate510.00KNaN2.03M1.62M
High Estimate510.00KNaN2.03M1.62M
Year Ago Sales247.00KNaN1.73M2.03M
Sales Growth (year/est)106.50%N/A17.10%-20.20%
Earnings HistorySep 14Dec 14Mar 15Sep 15
EPS Est-0.26-0.26-0.25-0.09
EPS Actual-0.22-0.21-0.19-0.08
Difference0.040.050.060.01
Surprise %15.40%19.20%24.00%11.10%
EPS TrendsCurrent Qtr.
Dec 15
Next Qtr.
Mar 16
Current Year
Dec 15
Next Year
Dec 16
Current Estimate-0.08N/A-0.43-0.49
7 Days Ago-0.08N/A-0.43-0.49
30 Days Ago-0.08N/A-0.43-0.49
60 Days Ago-0.08N/A-0.43-0.49
90 Days Ago-0.10N/A-0.47-0.57
EPS RevisionsCurrent Qtr.
Dec 15
Next Qtr.
Mar 16
Current Year
Dec 15
Next Year
Dec 16
Up Last 7 Days0N/A00
Up Last 30 Days0N/A00
Down Last 30 Days0N/A00
Down Last 90 DaysN/AN/AN/AN/A
Growth EstCYCCIndustrySectorS&P 500
Current Qtr.63.60%N/A-91.60%2.90%
Next Qtr.N/AN/AN/A13.10%
This Year51.70%N/A109.90%2.60%
Next Year-14.00%N/A32.10%9.30%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A25.99%18.95%4.91%
Price/Earnings (avg. for comparison categories)-0.88-3.681.1619.73
PEG Ratio (avg. for comparison categories)N/A0.140.661.98
Currency in USD.